[1] Milic S,Mikolasevic I,Orlic L,et al. The Role of Iron and Iron Overload in Chronic Liver Disease. Med Sci Monit,2016,22: 2144-2151.
[2] Li YM,Fan JG. Guidelines of prevention and treatment for alcoholic liver disease (2018, China). J Dig Dis,2019,20: 174-180.
[3] European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. J Hepatol,2018,69: 154-181.
[4] Mehta KJ,Farnaud SJ,Sharp PA. Iron and liver fibrosis: Mechanistic and clinical aspects. World J Gastroenterol,2019,25: 521-538.
[5] Tangudu NK,Buth N,Strnad P,et al. Deregulation of hepatic Mek1/2(-)Erk1/2 signaling module in iron overload conditions. Pharmaceuticals (Basel),2019,12: 70.
[6] Ganz T. Systemic iron homeostasis. Physiol Rev,2013,93: 1721-1741.
[7] Wang CY,Babitt JL. Liver iron sensing and body iron homeostasis. Blood,2019,133: 18-29.
[8] Kawabata H. The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis. Int J Hematol,2018,107: 31-43.
[9] Brissot P,Loreal O. Iron metabolism and related genetic diseases: a cleared land, keeping mysteries. J Hepatol,2016,64: 505-515.
[10] Czaja AJ. Review article: iron disturbances in chronic liver diseases other than haemochromatosis - pathogenic, prognostic, and therapeutic implications. Aliment Pharmacol Ther,2019,49: 681-701.
[11] Pietrangelo A. Ferroportin disease: pathogenesis, diagnosis and treatment. Haematologica,2017,102: 1972-1984.
[12] Anderson GJ,Frazer DM. Current understanding of iron homeostasis. Am J Clin Nutr,2017,106: 1559s-1566s.
[13] Brissot P,Pietrangelo A,Adams PC,et al. Haemochromatosis. Nat Rev Dis Primers,2018,4: 18016.
[14] Sonnweber T,Nachbaur D,Schroll A,et al. Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB. Gut,2014,63: 1951-1959.
[15] Poli M,Luscieti S,Gandini V,et al. Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation. Haematologica,2010,95: 1832-1840.
[16] Loreal O,Cavey T,Robin F,et al. Iron as a therapeutic target in hfe-related hemochromatosis: usual and novel aspects. Pharmaceuticals (Basel),2018,11: 131.
[17] Harrison-Findik DD. Is the iron regulatory hormone hepcidin a risk factor for alcoholic liver disease? World J Gastroenterol,2009,15: 1186-1193.
[18] Wang CY,Xiao X,Bayer A,et al. Ablation of hepatocyte Smad1, Smad5, and Smad8 causes severe tissue iron loading and liver fibrosis in mice. Hepatology,2019,70: 1986-2002.
[19] Kohgo Y,Ohtake T,Ikuta K,et al. Dysregulation of systemic iron metabolism in alcoholic liver diseases. J Gastroenterol Hepatol,2008,23 Suppl 1: S78-81.
[20] Anderson ER,Taylor M,Xue X,et al. The hypoxia-inducible factor-C/EBPalpha axis controls ethanol-mediated hepcidin repression. Mol Cell Biol,2012,32: 4068-4077.
[21] Xu YY,Tang YH,Guo XP,et al. HFE genetic variability and risk of alcoholic liver disease: a meta-analysis. J Huazhong Univ Sci Technolog Med Sci,2016,36: 626-633.
[22] Costa-Matos L,Batista P,Monteiro N,et al. Hfe mutations and iron overload in patients with alcoholic liver disease. Arq Gastroenterol,2013,50: 35-41.
[23] Grove J,Daly AK,Burt AD,et al. Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease. Gut,1998,43: 262-266.
[24] Goodnough JB,Ramos E,Nemeth E,et al. Inhibition of hepcidin transcription by growth factors. Hepatology,2012,56: 291-299.
[25] Millonig G,Ganzleben I,Peccerella T,et al. Sustained submicromolar H2O2 levels induce hepcidin via signal transducer and activator of transcription 3 (STAT3). J Biol Chem,2012,287: 37472-37482.
[26] Mueller K,Sunami Y,Stuetzle M,et al. CHOP-mediated hepcidin suppression modulates hepatic iron load. J Pathol,2013,231: 532-542.
[27] Oliveira SJ,Pinto JP,Picarote G,et al. ER stress-inducible factor CHOP affects the expression of hepcidin by modulating C/EBPalpha activity. PLoS One,2009,4: e6618.
[28] Lawen A,Lane DJ. Mammalian iron homeostasis in health and disease: uptake, storage, transport, and molecular mechanisms of action. Antioxid Redox Signal,2013,18: 2473-2507.
[29] Peyssonnaux C,Zinkernagel AS,Schuepbach RA,et al. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Invest,2007,117: 1926-1932.
[30] Choi SO,Cho YS,Kim HL,et al. ROS mediate the hypoxic repression of the hepcidin gene by inhibiting C/EBPalpha and STAT-3. Biochem Biophys Res Commun,2007,356: 312-317.
[31] Varghese J,James JV,Sagi S,et al. Decreased hepatic iron in response to alcohol may contribute to alcohol-induced suppression of hepcidin. Br J Nutr,2016,115: 1978-1986.
[32] Bridle K,Cheung TK,Murphy T,et al. Hepcidin is down-regulated in alcoholic liver injury: implications for the pathogenesis of alcoholic liver disease. Alcohol Clin Exp Res,2006,30: 106-112.
[33] Gerjevic LN,Liu N,Lu S,et al. Alcohol activates TGF-Beta but inhibits BMP receptor-mediated Smad signaling and Smad4 binding to hepcidin promoter in the liver. Int J Hepatol,2012,2012: 459278.
[34] Zmijewski E,Lu S,Harrison-Findik DD. TLR4 signaling and the inhibition of liver hepcidin expression by alcohol. World J Gastroenterol,2014,20: 12161-12170.
[35] Kohgo Y,Ohtake T,Ikuta K,et al. Iron accumulation in alcoholic liver diseases. Alcohol Clin Exp Res,2005,29: 189S-93S. |
